M

matookerepublic.com

@matookerepublic Fri, 05 Jul 2024 09:43:04

New HIV drug trials prove that an injection twice a year prevents HIV infection

A groundbreaking trial called PURPOSE 1 has yielded remarkable results, offering a promising alternative to daily pills for HIV prevention. The trial, sponsored by Gilead Sciences, involved 5,300 cisgender women in South Africa and Uganda, with 2,134 receiving a twice-yearly injection of the drug lenacapavir. None of the women who received the injection contracted HIV, […] The post New HIV drug trials prove that an injection twice a year prevents HIV infection first appeared on Matooke Republic.

read more

Other Headlines